Assertio Total Other Income Expense Net from 2010 to 2024

ASRT Stock  USD 0.97  0.01  1.41%   
Assertio Therapeutics Total Other Income Expense Net yearly trend continues to be comparatively stable with very little volatility. Total Other Income Expense Net is likely to outpace its year average in 2024. From the period from 2010 to 2024, Assertio Therapeutics Total Other Income Expense Net quarterly data regression had mean square error of 4140.8 T and mean deviation of  32,401,144. View All Fundamentals
 
Total Other Income Expense Net  
First Reported
1998-03-31
Previous Quarter
92 K
Current Value
171 K
Quarterly Volatility
31.3 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Assertio Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Assertio Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 3.2 M, Total Revenue of 128 M or Gross Profit of 112.5 M, as well as many indicators such as Price To Sales Ratio of 0.47, Dividend Yield of 0.0 or PTB Ratio of 0.52. Assertio financial statements analysis is a perfect complement when working with Assertio Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Assertio Therapeutics Correlation against competitors.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.

Latest Assertio Therapeutics' Total Other Income Expense Net Growth Pattern

Below is the plot of the Total Other Income Expense Net of Assertio Therapeutics over the last few years. It is Assertio Therapeutics' Total Other Income Expense Net historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Assertio Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Other Income Expense Net10 Years Trend
Pretty Stable
   Total Other Income Expense Net   
       Timeline  

Assertio Total Other Income Expense Net Regression Statistics

Arithmetic Mean(11,010,140)
Coefficient Of Variation(576.08)
Mean Deviation32,401,144
Median(2,121,000)
Standard Deviation63,427,456
Sample Variance4023T
Range267.1M
R-Value(0.21)
Mean Square Error4140.8T
R-Squared0.04
Significance0.45
Slope(2,983,063)
Total Sum of Squares56322.6T

Assertio Total Other Income Expense Net History

2024-10 M
2023-10.5 M
2022-26.6 M
2021-10 M
202036.6 M
2019-225.7 M
201841.4 M

About Assertio Therapeutics Financial Statements

Assertio Therapeutics shareholders use historical fundamental indicators, such as Total Other Income Expense Net, to determine how well the company is positioned to perform in the future. Although Assertio Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Assertio Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Assertio Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Total Other Income Expense Net-10.5 M-10 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.